Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Sales | 0 | 3,550 | 8,030 | 0 | 0 |
| Cost of Goods | N/A | 2,750 | 6,300 | 0 | 0 |
| Gross Profit | N/A | 790 | 1,730 | 0 | 0 |
| Operating Expenses | 350 | 2,730 | 2,390 | 160 | 40 |
| Operating Income | -350 | -1,180 | -360 | -160 | -40 |
| Interest Expense | 0 | 1 | 50 | 0 | 0 |
| Other Income | 244 | 191 | -730 | 330 | 240 |
| Pre-tax Income | -106 | -990 | -1,140 | 170 | 200 |
| Income Tax | N/A | 0 | 0 | 60 | 60 |
| Net Income Continuous | -106 | -990 | -1,140 | 110 | 140 |
| Net Income | $-106 | $-990 | $-1,140 | $110 | $130 |
| EPS Basic Total Ops | -3.00 | -17.08 | -19.38 | N/A | N/A |
| EPS Basic Continuous Ops | -2.63 | -17.08 | -19.38 | N/A | N/A |
| EPS Diluted Total Ops | -3.00 | N/A | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -2.63 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-350 | $-1,020 | $-160 | $-160 | $-40 |